The private sector, international development and NCDs

被引:46
|
作者
Hancock, Christine [1 ]
Kingo, Lise [2 ]
Raynaud, Olivier [3 ]
机构
[1] C3 Collaborating Hlth, London W1W 8RZ, England
[2] Novo Nordisk AS, DK-2880 Bagsvaerd, Denmark
[3] World Econ Forum, CH-1223 Cologny Geneva, Switzerland
关键词
CHALLENGES;
D O I
10.1186/1744-8603-7-23
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
This article addresses an area that has been largely underserved by the development community, and one in which there is a particularly good opportunity for the private sector to take a lead in making a difference to employees, customers and local communities: chronic, non-communicable diseases (NCDs). It highlights the extent of the epidemic of NCDs in developing countries, sets out the 'business case' for the private sector to act on NCDs, and gives examples of initiatives by business to ensure that the healthy choice really is an easier choice for employees, consumers and local communities. It makes the case that, to be genuinely sustainable, businesses should be addressing health as a core part of what they do and, by working in partnership - as called for by the Millennium Development Goals - they can make a real difference and become part of the solution. Identifying ways in which this can be done should form a key part both of planning for, and action after, the UN High-level Meeting on NCDs, to be held in September 2011.
引用
收藏
页数:11
相关论文
共 50 条